1. Cancer immunotherapy in patients with brain metastases

   • Salvatore Caponnetto
   • Arianna Draghi
   • Marco Donia

   Review 08 March 2018 Pages: 703 - 711

2. Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis

   • Tao Jiang
   • Meng Qiao
   • Caicun Zhou

   Original Article 08 February 2018 Pages: 713 - 727

   

3. Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node

   • Jonathan R. McDaniel
   • Stephanie C. Pero
   • David N. Krag

   Original Article 09 February 2018 Pages: 729 - 738

   

4. Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation

   • Shimrit Ringelstein-Harlev
   • Irit Avivi
   • Tami Katz

   Original Article 15 February 2018 Pages: 739 - 748

   

5. Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression

   • Albert T. Gacerez
   • Casey K. Hua
   • Charles L. Sentman

   Original Article 16 February 2018 Pages: 749 - 759

   

6. TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors

   • Sumit Mukherjee
   • Rahman Hussaini
   • Probal Banerjee

   Original Article 16 February 2018 Pages: 761 - 774

   

7. The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells

   • Daniela Dörfel
   • Christian J. Lechner
   • Susanne M. Rittig

   Original Article 21 February 2018 Pages: 775 - 783

   

8. Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model

   • Urska Kamensek
   • Maja Cemazar
   • Gregor Sersa

   Original Article Open access 21 February 2018 Pages: 785 - 795

   

9. Certain BCG-reactive responses are associated with bladder cancer prognosis

   • Guang Shan
   • Tian Tang
   • Yue Xia

   Original Article 24 February 2018 Pages: 797 - 803

   

10. PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma

    • Vinod Varki
    • Olga B. Ioffe
    • Dan P. Zandberg

    Original Article 27 February 2018 Pages: 805 - 814

    

11. The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models

    • Heinz Läubli
    • Philipp Müller
    • Alfred Zippelius

    Original Article 27 February 2018 Pages: 815 - 824

    

12. Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders

    • Katharina C. Kähler
    • Thomas K. Eigentler
    • For the German Dermatologic Cooperative Oncology Group (DeCOG)

    Original Article 27 February 2018 Pages: 825 - 834

13. Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens

    • James A. Koziol
    • Haruhiko Imai
    • Eng M. Tan

    Original Article 01 March 2018 Pages: 835 - 841

    

14. Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy

    • Aglaia Domouchtsidou
    • Vahé Barsegian
    • Monika Lindemann

    Original Article 02 March 2018 Pages: 843 - 853

    

15. The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12–13, 2017, Royal Society, London, UK

    • Angus G Dalgleish

    Meeting Report Open access 02 March 2018 Pages: 855 - 860